Virax Biolabs Stock Skyrockets 100% on Exclusive Distribution Agreement
Read the full articleWajeeh Khan3h ago
You might also wanna read
Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
thefly.com·11h ago
RQ Bio secures $115M Series A for virus-targeting antibody pipeline
RQ Bio has clinched $115 million in a Series A raise to advance a preclinical pipeline of virus-targeting antibodies.
endpoints.news·15d ago
Merck KGaA acquires Bio-Techne in $11 billion all-cash deal to bolster life sciences division
All-cash deal will strengthen the German company’s life sciences portfolio
cen.acs.org·13d agoVirax Biolabs: Asien-Deal mit Fosun Diagnostics treibt Aktie trotz Mini-Size massiv an
LONDON / LONDON (IT BOLTWISE) – Virax Biolabs meldet einen exklusiven Liefervertrag mit Fosun Diagnostics für sechs südostasiatische Märkte
IT BOLTWISE·9h ago
Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal
Merck KGaA's agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy
The Daily Upside·13d ago
Biocon stock ticks up as Yesafili Biosimilar clinical data gets published in peer-reviewed journals
CEO Shreehas Tambe called the publications an important milestone for the company’s aflibercept biosimilar programme
thehindubusinessline.com·16h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.